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Abstract
Microvascular lesions resulting from endothelial cell dysfunction are produced in the brain, lung, kidney, and retina of
patients of complex chronic diseases. The environmental and molecular risk factors which may contribute in the
development of microvascular damage are unclear. The mechanism(s) responsible for initiating microvascular damage
remain poorly defined, although several inciting factors have been proposed, including environmental toxicants-induced
oxidative stress. Enhanced neovascularization has been implicated in either the development or progression of proliferative
vascular lesions. Here, we present evidence for how PCB-induced ROS may contribute to the development of a neovascular
phenotype with the aim of elucidating the role of environmental toxicants in endothelial dysfunction with a specific focus
on the inhibitor of differentiation protein ID3. We used a combination of phenotype and immunohistochemical analysis
followed by validating with protein expression and post-translational modifications with Western Blot and MALDI-TOF/TOF
analysis. We also looked for a correlation between ID3 expression in vascular tissue. Our results showed that PCB-induced
ROS mediated a highly tube branched neovascular phenotype that also depended on ID3 and Pyk2; and PCB153 treatment
increased the size of endothelial spheroids under conditions typically used for clonal selection of stem cell spheroids. High
ID3 protein expression correlated with a greater degree of malignancy and oxidative DNA damage marker 8-OHdG in blood
vessels from human subjects. PCB153 treatment increased both serine and tyrosine phosphorylation of endothelial ID3.
Stable ID3 overexpression increased cell survival of human microvascular endothelial cell line hCMEC/D3. In summary, our
data provide evidence that ID3 may play a critical role in regulating vascular endothelial cell survival and development of
microvascular lesions induced by persistent environmental pollutants such as PCB153. Findings of this study are important
because they provide a new paradigm by which PCBs may contribute to the growth of microvascular lesions.
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Introduction
The endothelium is a highly metabolically active organ
weighing approximately 1 kg and covering a total surface area
of 4000–7000 m2 in an average-sized human [1]. It is noteworthy
that the underexplored microvasculature represents the largest
fraction of the total vascular cross-sectional area and may hold
important clues that link environmental pollutants to vascular
disease. Microvascular complications have been shown to
contribute to the development of cardiovascular disease, diabetic
retinopathy, and neurological disease. Furthermore, proliferative
microvascular lesions that result from a focal budding of
endothelial cells (ECs) have been reported to be an aggressive
endothelial phenotype associated with a poor prognosis in
glioblastoma multiforme, non-small cell lung cancer, and severe
idiopathic pulmonary arterial hypertension [2–4]. The risk factor
and possible molecular mechanisms responsible for the develop-
ment of microvascular lesions are still largely unknown. Since
environmental polychlorinated biphenyls (PCBs) have been
reported in human blood [5]; vascular toxicity from PCB exposure
is a public health concern. Evidence in support of vascular toxicity
from PCBs comes from epidemiological studies that have shown
the link between PCB exposure and risk for vascular disease [6–9].
However, how exposure to PCBs may affect the development of
microvascular lesions is not clear. PCBs are a class of commercially
synthesized chemicals that were used worldwide for electrical
equipment, hydraulic machinery, and as additives in pesticides,
paints, ink, and plastics during the 1930s through the mid-1970s.
The stability of these chemicals has allowed them to persist in the
environment and consequently continues to expose the general
population to PCBs mainly via the food-chain. In the present
study, we determined whether PCB-induced reactive oxygen
species (ROS) contributed to the development of an endothelial-
like lesion.
We have previously shown that ID3 is an important determi-
nant of ROS-induced proliferation of estrogen exposed ECs [10],
however, the effect of environmental PCBs on Id proteins has not
been investigated until now. The Id (inhibitors of DNA binding
and differentiation) family of proteins family of proteins consists of
four genes (Id1–Id4). ID3 is expressed in ECs during embryogen-
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esis, but is down-regulated as tissues mature [11]. Id protein-
protein interactions occur via the helix-loop-helix (HLH) motif in
which Id proteins dimerize with basic HLH transcription factors.
This type of Id interaction has been reported to regulate
transcription in a dominant-negative manner [12]. Id proteins
have also been reported to bind to proteins that do not contain the
HLH motif such as caveolin-1 [13]. Besides negative regulation of
cell differentiation, Id proteins also act as positive regulators of cell
growth and play a major role in neovascularization [12]. Since
ID3 is a redox-sensitive gene that has been implicated in vascular
lesion formation [14–16], we hypothesize that ID3 is involved in
the development of the microvascular lesion in response to the
environmental toxicants. Here, we have elucidated the role of
environmental PCBs in endothelial dysfunction with a specific
focus on ID3 by showing evidence that ID3 may play a critical role
in regulating vascular endothelial cell survival and development of
microvascular lesions induced by the persistent environmental
pollutant, PCB153. A better understanding of how microvascular
lesions depend on ID3 may open up new avenues for prevention
and treatment of diseases that harbor microvascular lesions.
Materials and Methods
Cell culture and treatment conditions
Primary cells, Human umbilical vein endothelial cells (HU-
VECs) and normal human dermal fibroblasts (NHDF), were
purchased from Cambrex. HUVECs (passages 2–10) were
maintained in endothelial cell basal medium-2 (EBM-2) supple-
mented with EGM2-MV SingleQuots (Cambrex). NHDF (pas-
sages 3–6) were maintained in monoculture in EBM-2 supple-
mented with FGM-2 SingleQuots (Cambrex). The effect of PCB
treatment on HUVECs was studied under the following culture
conditions: HUVECs were starved in phenol red-free mammary
epithelium basal medium in the absence of serum and growth
factors for 3 h. Thereafter, the cells were treated with PCB153
(2,29,4,49,5,59-hexachlorobiphenyl) and PCB77 (3,39,4,49-tetra-
chlorobiphenyl) for the indicated time periods. PCB congeners
were purchased from AccuStandard (New Haven, CT) and
dissolved in dimethyl sulfoxide (DMSO). Equal volumes of
DMSO as in PCB treatment group were added to vehicle control
with the final percentage of DMSO in each group to be less than
0.1%. The effect of ROS scavengers (N-acetylcysteine and ebselen)
was studied by pretreating the cells for 2 h prior to PCB exposure.
For ROS scavenger enzyme studies, HUVECs were incubated
with replication-deficient adenoviral constructs containing human
MnSOD and catalase (Ad-MnSOD and Ad-CAT, ViraQuest Inc)
at 50 multiplicities of infection (MOI) for 24 h. The immortalized
human cerebral microvascular endothelial cell line hCMEC/D3
was obtained from Dr. B. Weksler, Weill Medical College of
Cornell University, NY. The hCMEC/D3 cells have been shown
to retain their EC characteristics with a stable normal karyotype,
proliferate in response to endothelial growth factors, and form
capillary tubes in matrix but no colonies in soft agar [17]. The
hCMEC/D3 cell line was maintained in DMEM-F12 media with
5% FBS. Cells were cultured at 37uC in a humidified atmosphere
with 5% CO2.
Endothelial tube assay on matrix gel
HUVECs were seeded on top of the solidified Cultrex Matrix
(Trevigen) in the presence or absence of E2 for 5 h. Tube
formation on the Cultrex Matrix was observed under the
microscope and photographed with an Olympus C-5060 digital
camera. AdobePhotoshop was used for conversion to black and
white photos. Triplicates were used in all experiments and each
experiment was repeated at least three times. For quantification of
tube formation the number of branch points of the formed tubes
was counted as described by Soares et al. [18]. Data shown are
expressed as mean 6 SD and statistical significance was
determined using Student’s t-test with P-values smaller than 0.05
considered as significant.
Co-culture tube assay
In a 24-well plate, HUVECs were seeded on top of NHDF in
phenol red-free mammary epithelium basal medium. Simulta-
neously, cells were treated with PCBs, ROS scavengers, or the
vehicle control (0.1% DMSO) for 3 days. The ELISA was
performed as described by Friis et al. [19] The endothelial tube
structures were photographed and quantified as described
previously. Triplicates were used in all experiments and each
experiment was repeated at least three times. For RNA
interference (RNAi) studies, HUVECs were cultured in 6-well
plates to 60% confluency. Transfection was performed using
FuGENE 6 (Roche) according to the manufacturer’s protocol. ID3
siRNA and Pyk2 siRNA was designed, synthesized, and annealed
by Ambion with the following sequences: ID3 Sense: 59-
GGAGCUUUUGCCACUGACUTT-39, ID3 Antisense: 59-
AGUCAGUGGCAAAAGCUCCTT-39; and Pyk2 Sense: 59-
GGUCUGCUUCUAUAGCAACTT-39, Pyk2 Antisense: 59-
GUUGCUAUAGAAGCAGACCTT-39. The FuGENE:siRNA
mixture (100 ml/well) was added to HUVECs in EBM-2 and
returned to the incubator for 48 h prior to co-culture experiments.
Silencer negative control siRNA (Ambion) was used in all RNAi
experiments.
Endothelial spheroid assay
Cells were suspended in serum-free DMEM/F12 (1:1) culture
medium supplemented with B27. For EC spheroid formation,
approximately 100–150 cells per well were seeded in an ultra low-
attachment 96-well plate (Corning Inc, Lowell, MA). The effect of
ROS scavenger N-acetylcysteine was determined by pre-treating
the cells with 3 mM NAC 1 h prior to exposure with 60 mM
PCB153 on the day of seeding cells. Endothelial spheroids were
grown for 10 days in liquid culture in the absence or presence of
PCB153. A total of 15 endothelial spheroids with a minimum
diameter of 50 mm were counted in each experimental group.
Data were analyzed by ANOVA; Tukey HSD test for multiple
comparisons.
Tissue microarray analysis of ID3 expression
Immunohistochemistry: ID3 expression was determined in a
cardiovascular disease tissue microarray designed for blood vessel
or endothelial cell related studies (Cat. #CVD481, US Biomax,
Inc). For immunohistochemical preparation: In brief, paraffin
embedded tissue sections were placed in xylene and were gradually
re-hydrated in successive steps with ethanol (100%, 95%, 70%)
and PBS, pH 7.4. Then tissues were blocked with 3% normal goat
serum and incubated with antibodies: anti-ID3 overnight at 4uC.
After washing with 1X PBS, tissues were incubated with anti-
rabbit-IgG were counterstained with hematoxylin QS and with
serially dehydrated in ethanol (25%, 50%, 75%, 95% & 100%).
Then tissues were dipped in xylene and placed on cover slip with
histological mounting medium.
Immunofluorescence preparation: Paraffin embedded tissue
sections were placed in xylene and were gradually re-hydrated
in successive steps with ethanol (100%, 95%, 70%), PBS, pH 7.4.
and treated for antigen unmasking with 10 mM sodium citrate
buffer, pH 6.0. Then slides were incubated in 3% normal goat
serum and washed in PBS with 0.5% Tween 20 (PBST). Slides
PCB153-Induced Endothelial ID3
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were incubated with primary antibodies anti-ID3 and anti-8-
hydroxydeoxyguanosine (8-OHdG) for overnight at 4uC, washed
in PBST and incubated with anti-rabbit-IgG Alexa Fluor 546 for
ID3 and anti-mouse-IgG Alexa Fluor 633 for 8-OHdG, washed in
PBST and mounted with Fluoromount-G slide mounting medium.
Images were captured with DeltaVision ELITE Olympus IX71
fluorescence microscope, Applied precision (Thermo Scientific)
using software softWoRx-Acquire Version: 5.5.1 Release 3.
Immunostaining of ID3 was semi-quantitatively evaluated by
assigning a score for the intensity of the immunohistochemical
reaction and for the proportion of the ID3 cells stained as
previously described by Wilson et al. The product of these two
values was taken to give the overall IR (total score). The intensity
of the immunohistochemical reaction (intensity score) was
stratified into four categories: 0, no IR; 1, weak IR; 2, moderate
IR; and 3, strong IR. All statistics were performed using Spearman
Rank Correlation (v1.0.1) in free Statistics Software (v1.1.23-r7),
Office for Research Development and Education, by Wessa P
(2012), website: http://www.wessa.net/rwasp_spearman.wasp ac-
cessed on 02/18/2014.
Immunoblotting
Whole cell lysates were prepared with lysis buffer containing
[25 mM Tris-HCl buffer (pH 8.0), 150 mM NaCl, 0.2% NP-40,
10% glycerol, 8 mM b-glycerophosphate, 2.5 mM sodium pyro-
phosphate, 10 mM NaF, 0.2 mM Na3VO4, 1 mM DTT and
10 ml/ml protease inhibitor cocktail (Sigma Aldrich). Proteins were
quantified using the Bradford Assay Reagent (Bio-Rad) according
to the manufacturer’s instructions. Proteins (35–75 mg) were
separated by 10% SDS-PAGE and transferred to polyvinylidene
fluoride (PVDF) membranes (Millipore). Membranes were blocked
with 5% nonfat milk and incubated with the following antibodies:
ID3 (Cal BioReagent), CD31, pY402-Pyk2, Pyk2, and p-Ser (Santa
Cruz BioTechnology); p-Tyr and b-actin (Cell Signaling). Anti-
body dilutions used were according to manufacturer’s recommen-
dations for detection by immunoblot. Membranes were then
incubated with horseradish peroxidase-conjugated secondary IgG
antibodies and visualized with ECL Plus Western blot reagents
(GE Healthcare, Amersham). The membranes were re-probed for
b-actin as loading control. Electrochemiluminescence (ECL)
intensity of detected target proteins was imaged and quantified
with a Bio-Rad Versa Doc instrument. All immunoblots were
completed a minimum of three times for each experiment.
Immunoprecipitation
For immunoblots of immunoprecipitated (IP) lysate the
following method was used. ID3 protein was pulled down using
magnetic beads (Dynabeads protein G). In Brief, the lysate were
incubated with 10 mg of antibody and 50 ml (1.5 mg) of
Dynabeads (Invitrogen) in micro-centrifuge tubes with rotation
for 10 minutes at room temperature. Samples were then placed on
a magnetic particle concentrator (DynaMagTM-2, Invitrogen) and
supernatant was discarded. Dynabeads–Ab–Ag complex was
washed 3 times with washing buffer and tubes were placed on
magnetic particle concentrator to remove the supernatant. The
magnetic Dynabeads–Ab–Ag complex was suspended with 20 ml
of Elution Buffer and boiled in SDS sample buffer for 5 min.
Samples were placed on the magnetic particle concentrator and
supernatant containing protein were separated by SDS-PAGE and
immunoblotted as described above.
Phospho-peptide identification by (MALDI-TOF/TOF)
mass spectrometry
The services of Applied Biomics (Hayward, CA, USA) were
used for the identification of phosphorylation sites by MALDI-
TOF/TOF following a standard protocol. In brief, after the
PCB153 treatment total cell lysates were immunoprecipitated with
ID3 and separated on a 1D gel. The gel bands corresponding to
ID3 protein were reduced, alkylated, and subjected to trypsin
digestion. Supel-Tips (Sigma-Aldrich) were used for phosphopep-
tide enrichment. Tryptic peptides were desalted by Zip-tip C18
(Millipore), and peptides were eluted from the Zip-tip with 0.5 ml
of Matrix solution (Agilent Technologies) and spotted on the
MALDI plate. MALDI-TOF MS (matrix-assisted laser desorp-
tion/ionization–time-of-flight MS) was performed on an AB Sciex
Proteomics Analyzer (AB Sciex, Foster City, CA, USA). MS
spectra were acquired in positive ion mode and ,4000 laser
shots/per spectrum. A virtual digest was done by submitting
protein sequences of interest to University of California–San
Francisco Protein Prospector (http://prospector.ucsf.edu/
prospector/mshome.htm). The MS precursors matching the
virtual digest were submitted for MS fragmentation. The resulting
peptide masses were submitted to MASCOT search engine
(Matrix Science) to search the database of Swiss-Prot. Candidates
with either protein score C.I.% or ion C.I.% .95 were considered
significant. The spectra of all peptides containing potential
phosphorylation sites were manually evaluated for the loss of
phosphate.
In vitro kinase assay
FLAG-ID3 in vitro kinase assay: Active recombinant human
Pyk2 kinase (0.1 mg/ml, Signal Chem) was added with ATP
(10 mM, Signal Chem), ID3 protein (Recombinant protein with
GST–Myc-DDK/FLAG, TP300583, OriGene), and incubated
37uC overnight. Samples were kept in 4uC for 10 min and boiled
in SDS sample buffer for 5 min. Samples were seperated by 12%
SDS-PAGE and immunoblotted as described previously. GST-
ID3 in vitro kinase assay: Active recombinant human Pyk2 kinase
(0.1 mg/ml, SignalChem) was added with ATP (10 mM, Signal
Chem), with ID3 protein (Recombinant protein with GST–Tag,
AAH03107, Abnova), and processed as described previously.
ID3 overexpression
The hCMEC/D3 cells were stably transfected with with either
Precision LentiORF for ID3 (Thermo Scientific Open Biosystems)
or empty vector lentiviral pLEX-JRED/TurboGFP by the trans-
lentiviral packaging kit with Express-in transfection reagent
according to the manufacturer’s instructions. We used the MOI
(multiplicity of infection) of 25 and selected cells that overex-
pressed ID3 with blasticidin S (5 mg/ml) as per manufacturer’s
instructions. Cells expressing TurboGFP were identified by
fluorescence microscopy.
FITC Annexin V Apoptosis detection
Cell apoptosis was assessed by using FITC Annexin V Apoptosis
Detection Kit I (BD Pharmingen) according to the manufacturer’s
protocol. Briefly, cells were washed with cold PBS and then
resuspended in 1X binding buffer, and 100 ml of solution
containing cells were stained with 5 ml Annexin V-FITC and
5 ml propidium iodide (PI). After incubation in the dark for
15 min, 100 ml of 1X binding buffer was added and cells were
analyzed by Guava easyCyte using the CytoSoft software program
according to the manufacturer’s instructions.
PCB153-Induced Endothelial ID3
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Results
PCB-induced ROS and ID3 mediate neovascularization
ECs acquire a proliferative and invasive phenotype in the
neovascular process; and there is some evidence that disorders
such as microvascular lesion formation exploit this phenotype.
Development of microvascular lesions has been described mech-
anistically as a neovascular process gone awry [4,20]. The concept
of oxidative stress or the excess of ROS that triggers the
development of vascular disease has been implicated as a
mechanism by which environmental pollutants may exert their
adverse effects. Several studies have demonstrated that PCBs can
induce oxidative stress in human vascular ECs [21–25]. Thus, it is
biologically plausible that ECs that line the lumen of blood vessels
are under increased oxidative stress from exposure to PCBs.
Various PCB congeners have been shown to exert neovascular
actions in cells. Therefore, we used the endothelial tube assay to
determine whether PCB-induced neovascularization depended on
ROS. Human umbilical vein endothelial cells (HUVECs) were
cultured on top of Cultrex Reduced Growth Factor Matrix. In
Panel A of Figure 1, a 5 h exposure to both PCB congeners 153
and 77 [1 ng/ml] resulted in a well developed tube network
compared to vehicle control (0.1% DMSO). Next, we ascertained
whether the individual ROS relevant to mediating this PCB-
induced phenotype was either superoxide radical (O2N
––) or
hydrogen peroxide (H2O2) by overexpressing ROS scavenging
enzymes. NADPH oxidase has been identified as a source of O2N
––
production in PCB exposed ECs [26]. To determine whether
PCB-induced tube formation depended on O2N
–, HUVECs were
transduced with an adenoviral vector expressing the enzyme
MnSOD (Ad-MnSOD) which is capable of dismutating O2N
––. As
shown in Panel B of Figure 1, overexpression of MnSOD inhibited
tube formation and resulted in rounded EC colonies with few
branch points in PCB treated cells compared to the vector control.
Studies have shown that selectively overproducing or removing
H2O2 significantly altered vascular lesion formation in animal
models [27]. Thus, we determined whether H2O2 contributed to
PCB-induced tube formation by overexpressing the H2O2
scavenging enzyme catalase. HUVECs were transduced with
Ad-CAT. As shown in Panel C of Figure 1, overexpression of
catalase similarly inhibited the PCB-induced endothelial tube
network.
Although endothelial tube assays performed on matrix gel are
commonly used to determine EC vessel formation in vitro,
Donovan et al. [28] have demonstrated that tube formation on a
matrix gel is not specific for ECs. Moreover, they reported that
endothelial vessel morphology from co-cultured cells better
represents EC sprouting that occurs in vivo. Hence, we further
verified the contribution of ROS in PCB-induced neovascular
formation with the co-culture assay. HUVECs were seeded on top
of a confluent layer of fibroblasts and treated with PCB153,
PCB77, ROS scavengers, or the vehicle control (DMSO) for 72 h.
Cell cultures were immunostained for endothelial marker CD31
and showed significant tube networks in both PCB153 and PCB77
treated cells compared to control (Fig. 2A). Pretreatment with the
ROS scavengers, ebselen and N-acetylcysteine (NAC) resulted in
EC morphology of short tubes with significantly fewer branches
than with the PCB treatments alone. Inhibition of PCB-induced
neovascular phenotype by ROS modifiers was quantified by
counting the mean number of branch points. Results are shown in
Fig. 2B where the quantification of branch points was evaluated in
micrographs from four fields of each well. Our PCB-induced
endothelial phenotype changes shown in both the matrix gel and
co-culture EC tube assays confirmed that ROS support the
development of a significant neovascular network in HUVECs
exposed to both the non-dioxin-like PCB153 and dioxin-like
PCB77. Although a previous study reported significant ROS
production from exposure to PCB77, but not with PCB153 [25];
the conditions used in our experiments were not similar. Our
experimental conditions differed in that we used a human EC
model and a far lower dose of PCB153. These major differences in
conditions can account for the observed ROS dependent tube
formation seen in the PCB153 treatment. In further support of our
data, a more recent study reported that human brain ECs exposed
to 5 mM of PCB153 significantly produced ROS [26].
ID3 has been implicated in vascular lesion formation in
response to injury and in native atherosclerosis [29]. PCB
exposure is known to induce ROS in ECs and since ID3 is
regulated by the redox status of the cell, we determined whether
ID3 was critical for the observed PCB-induced neovascular
phenotype. To our knowledge, the effects of PCBs on Id proteins
in ECs have not been previously studied. Therefore, cellular levels
of ID3 were knocked down by siRNA and phenotype changes
were determined with the co-culture tube assay as described
previously. HUVECs were transfected with ID3 siRNA [50 nM]
or Silencer negative control siRNA (Ambion) for 48 h prior to co-
culture experiments. Cells were treated with PCB153 and PCB77
as described previously for 72 h. Immunostaining for the
endothelial marker CD31 was used to visualize vessel formation.
In Fig. 2C, ID3 siRNA treatment showed a significant reduction
in PCB-induced vessel formation by both PCB congeners 153 and
77 compared to the negative control. The inhibition of neovas-
cularization by ROS scavengers and siRNA knockdown of ID3,
suggest that PCBs exert these changes in EC phenotype by ROS-
signaling pathways.
PCB153-induced endothelial spheroid formation
Recent data from our laboratory showed that ID3 induced a
molecular stem cell-like signature—CD133+ VEGFR3+ CD34+ in
microvascular ECs (in press). Even though blood vessels are lined
by a single layer of ECs, cells in vascular lesions do not follow the
‘‘law of the monolayer.’’ Rather than growing in a flat monolayer,
the ECs grow in three dimensions similar to tumors. Spheroid
formation is known to correlate with cell survival or increased
resistance to apoptosis. Since hyper-proliferative, apoptosis-resis-
tant, and monoclonal ECs have been characterized in microvas-
cular lesions [30]; we used a stem cell sphere forming assay to
determine the influence of PCB153 and ROS on the formation of
endothelial spheroids.
The non-dioxin-like PCB congener 153 accounts for 15–30% of
total PCB content in most human samples and highly ortho-
cholorine-substituted PCBs like PCB153 have been reported to
accumulate in the brain [31]. We continued our experiments using
the immortalized human cerebral microvascular endothelial cell
line hCMEC/D3. PCB153 treated hCMEC/D3 have already
been shown to produce ROS [26], hence we further determined
whether PCB153 or ROS could support the growth of EC
spheroids. The effect of a single dose of PCB153 on the survival of
hCMEC/D3 cultured in non-adherent round bottom plates and
B27 supplemented DMEM/F12 media was assessed for 24 h.
Under these conditions stem-like cells were subjected to the MTT
assay and cell viability was determined. PCB153 inhibited
hCMEC/D3 cells with 50% survival (LC50) at 100 mM (Fig. 3A).
Therefore, we treated hCMEC/D3 cells to a single dose of 60 mM
of PCB153 for 10 days. It is important to note that toxicity of
PCB153 exposed hCMEC/D3 differed greatly when cells were
exposed in routine monolayer culture conditions. In monolayer
culture, the LC50 was 45 mM (Fig. 3B) which is to be expected
PCB153-Induced Endothelial ID3
PLOS ONE | www.plosone.org 4 August 2014 | Volume 9 | Issue 8 | e104159
because cells in monolayer are composed of a heterogeneous
population of quiescent, progenitor, senescent, and dead cells that
may be less tolerant to PCB exposure when compared to more
resilient stem-like cells that are selected for by the sphere assay.
Using the stem cell sphere assay described previously, ECs were
treated with PCB153 to determine whether this exposure selected
for the formation of endothelial spheroids. Measurements of the
diameters of individual endothelial spheres were taken at days 0, 5,
and 10. As shown in Fig. 3C, PCB153 treatment resulted in
significantly larger endothelial spheroids at both days 5 and 10
compared to vehicle control (0.1% DMSO). In vehicle control, the
stem cell sphere assay selected for the survival and growth of stem-
like endothelial colonies that was enhanced by PCB153 treatment.
The majority of research on PCB-induced ROS has focused on
their cellular toxicities. Based on our previous data showing ROS
scavengers inhibited PCB-induced neovascularization, hCMEC/
D3 cells were pre-treated for 1 h with 3 mM of NAC prior to
PCB153 treatment on the day of cell seeding. Our data showed
that NAC significantly inhibited the size of PCB153-induced
endothelial spheroids in both the vehicle control and PCB153
groups. The significant reduction in the size of endothelial
spheroids by NAC treatment alone when compared to control
showed that endogenous levels of ROS contributed to sphere
formation and cell survival. This importance of endogenous ROS
levels was not surprising because clonal stem cell sphere formation
and self-renewal have been reported to depend on high
endogenous ROS levels [32]. Based on our data, the individual
contributions of ROS from cellular metabolism or PCB exposure
to spheroid formation cannot be distinguished. However, the
findings that showed PCB153 increased the size of endothelial
spheroids and survival is novel. Even though the sphere forming
assay is widely used to select for stem-like cells under serum-free
culture conditions, this is the first report to our knowledge that
included exposure to environmental PCBs.
ID3 expression correlated with benign and malignant
cardiovascular tissues
Id proteins are positive regulators of cell growth and play a
major role in neovascularization. High levels of ID3 mRNA
Figure 1. PCB-induced neovascularization phenotype depends on ROS. Representative micrographs showing inhibition of endothelial tube
formation in HUVECs cultured in a matrix gel and exposed for 5 h to PCB congeners 153 and 77 (Panel A). Co-treatments with antioxidant enzymes
MnSOD (Panel B) and catalase (Panel C) were used to determine the contribution of specific ROS. HUVECs were treated with vehicle control (0.1%
DMSO) or 1 ng/ml of PCB153 and PCB77 for 5 h. For antioxidant enzyme overexpression, prior to treatment HUVECs were incubated with replication
deficient adenoviral constructs containing human MnSOD, catalase, or empty vector (ViraQuest Inc.) at 50 multiplicities of infection (MOI) for 24 h.
HUVECs were treated with 1 ng/ml of PCB153 (2,29,4,49,5,59-hexachlorobiphenyl) or PCB77 (3,39,4,49-tetrachlorobiphenyl).
doi:10.1371/journal.pone.0104159.g001
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expression have been reported in the rat carotid injury model [14].
It is not clear whether ID3 mRNA levels are a reliable marker of
phenotyping microvascular lesion formation. Based on our
findings that showed siRNA ID3 suppressed PCB-induced
neovascularization, we first performed immunohistochemical
microscopy of ID3 protein expression in a tissue microarray of
malignant, benign, and normal human vascular tissue specimens.
We used a cardiovascular disease tissue microarray (US Biomax)
that was designed for blood vessel or EC related studies.
Immunostaining of vessels with ID3 was semi-quantitatively
evaluated by assigning a score for the intensity of the immuno-
histochemical reaction and for the proportion of the ID3 cells
stained. The product of these two values was taken to give the
overall immunoreactivity (IR) score. The intensity of the
immunohistochemical reaction (intensity score) was stratified into
four categories: 0, no IR; 1, weak IR; 2, moderate IR; and 3,
strong IR. In adult normal heart, ECs did not exhibit detectable
amounts of ID3 protein (arrowhead) Fig. 4A. In contrast, strong
immunostaining was detected for ID3 in vessels from benign and
malignant heart specimens (arrows). Slides were counter-stained
with hematoxylin QS. In Fig. 4A, blood vessels (arrows) in
malignant heart tissue showed thickened walls with partially
occluded lumens and robust ID3 staining of ECs that lined the
lumen compared to the lumens found in the benign heart vessels
(arrows). Fig. 4B showed the ID3 IR score distribution in heart
specimens with different degrees of histological malignancy.
Spearman’s rank correlation test showed a significant correlation
between ID3 immunostaining and degree of malignancy with the
ID3 IR scores significantly higher in benign compared to normal
(p = 0.04) and in malignant compared to normal (p = 0.02). Since
the regulation of ID3 expression is known to depend on cellular
redox status, we further determined whether the protein levels of
ID3 and a marker of oxidative DNA damage, 8-hydroxydeox-
yguanosine (8-OHdG), correlated with the degree of malignancy.
Figure 2. ROS scavengers and siRNA ID3 inhibit the PCB-induced neovascular phenotype. PCB-induced vessel formation was further
characterized in a co-culture model. HUVECs were seeded on top of a confluent layer of fibroblasts (Fb). (A) Representative micrographs showing
inhibition of endothelial tube formation. Cells were pretreated with ROS scavengers: ebselen (Ebs.) or N-acetylcysteine (NAC) for 2 h prior to
treatment with 1 ng/ml of PCB153 and PCB77. Immunostaining for the endothelial marker CD31 at day 3 showed significant tube formation in the
PCB treatment groups compared to vehicle control (0.1% DMSO) that was suppressed by ebselen and NAC treatment. (B) The effect of ROS
scavengers on PCB-induced endothelial tube formation was quantified by counting the number of branch points. Co-cultures were established in
triplicate and data are expressed as mean6 S.D. between different wells. Measurements were performed from a representative experiment repeated
three times in triplicate. (*) PCB treatment significantly different from vehicle control. (**) ROS scavenger treatment significantly different from PCB
(P,0.05). (C) ID3 siRNA treatments inhibit PCB—induced tube formation in HUVECs co-cultured with fibroblasts at 3 days. Immunostaining for the
endothelial cell marker CD31 was used to visualize vessel formation. HUVECs were transfected with ID3 siRNA [50 nM] for 48 h prior to co-culture
experiments. Scrambled siRNA (Silencer negative control siRNA, Ambion) was used in all RNAi experiments. The data shown are representative
images from an experiment repeated three separate times.
doi:10.1371/journal.pone.0104159.g002
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In Fig. 4C, immunofluorescence staining of ID3 (green) and 8-
OHdG (red) in the malignant, benign, and normal human heart
vascular tissue specimens are shown. As described previously,
immunoreactivity scores for ID3 and 8-OHdG were semi-
quantitatively determined and reported in scatter plots of IR
scores vs. ID3 & 8-OHdG labeling index for each degree of
histological malignancy (Fig. 4D). Labeling index (LI) represents
the percentage of the immunostained cells per total number of
cells. We observed a higher ID3 & 8-OHdG LI in both malignant
and benign tissues compared to normal tissue (p,0.05, Mann-
Whitney U-test). In Fig. 4E, immunofluorescence staining of Id3
(green) and 8-OHdG (red) are shown in main artery tissue. ID3 &
8-OHdG LI for benign are greater than normal artery tissue
(Fig. 4F; p,0.05, Mann-Whitney U-test). In summary, the
findings from the tissue microarray showed that a higher
expression of ID3 protein correlated with a greater degree of
malignancy in blood vessels of heart tissue. The mechanism
accounting for this perturbation of ID3 expression under different
degrees of histological malignancy is not known, however, our
immunofluorescence data showed a correlation between oxidative
DNA damage marker 8-OHdG and ID3.
PCB153-induced ID3 expression depends on ROS but not
on AhR signaling
Vascular cell growth has been shown to be regulated by serine
phosphorylated ID3 [33]. We previously have shown that estradiol
exposure to HUVECs increased the serine phosphorylation of ID3
via ROS. Although our earlier experiments show that ID3 siRNA
inhibited PCB-induced neovascularization of HUVECs, the effect
of PCB153 exposure has on ID3 in the microvascular cell line
hCMEC/D3 was not known. Therefore, we determined whether
Figure 3. PCB153 treatment increased the survival and size of endothelial spheroids. (A) Graph of cell survival from exposure to PCB153
in B27 media determined by MTT assay of endothelial spheroids. Cell survival was determined 24 h after exposure. LC50,100 mM. Results shown are
averages of triplicates6 SD (,10%). (B) Graph of cell survival from exposure to PCB153 in monolayer culture in routine culture media determined by
MTT assay. Cell survival was determined 24 h after exposure to PCB153. LC50,45 mM. Results shown are averages of triplicates 6 SD (,10%). (C)
PCB153 (60 mM) treatment increased the diameter of endothelial spheroids measured at both days 5 and 10. The hCMEC/D3 cell line was cultured
with serum free B27 medium in ultra-low attachment 96 well plates. Spheroid diameter was measured at days 5 and 10. The measurement scale was
100 mm at a magnification of 2006. Error bars represent the mean diameter of 15 spheroids6 SD. Data were analyzed by ANOVA; Tukey HSD test for
multiple comparisons. Endothelial spheroid size is the mean diameter of 15 spheroids per treatment group 6 SD. ap,0.01; bp,0.01; cp,0.01 vs
control within 5 and 10 days as well as ep,0.01; fp,0.05 vs control between 0 and 5 days and gp,0.01; hp,0.01 vs control between 0 and 10 days.
Representative microphotographs of treatment groups are shown inset.
doi:10.1371/journal.pone.0104159.g003
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Figure 4. ID3 protein and oxidative damage is highly expressed in benign and malignant cardiovascular tissues. (A) Representative
immunohistochemical analysis of heart tissue using ID3 rabbit monoclonal antibody. ECs from normal tissue did not exhibit detectable amounts of
ID3 protein (arrowhead) while (arrows) indicated brown color as highest expression level for ECs with ID3 in vessels from benign and malignant heart
tissue. Counter-stained with Hematoxylin QS. Magnification 2006. (B) Scatter plot of immunoreactivity (IR) score vs. ID3 in normal, benign, malignant
heart. Spearman’s rank correlation test showed a significant correlation between ID3 immunostaining and degree of malignancy with the ID3 IR
scores significantly higher in benign compared to normal (p = 0.04) and in malignant compared to normal (p = 0.02). (C) Immunofluorescence staining
of ID3 (green) and 8-OHdG (red) in heart tissue. Scale = 20 mm. (D) Scatter plot of immunofluorescence (IF) score vs ID3 & 8-OHdG labeling index (LI)
in normal, benign, and malignant heart. IF score represents total score taken as the product of fluorescence intensity score and the cell score.
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hCMEC/D3 exposed to PCB153 showed increased ID3 serine
phosphorylation (p-Ser) and expression. As shown in Fig. 5A,
PCB153 exposure significantly increased the levels of p-Ser ID3
and total ID3 protein expression at 3 h. PCBs have been reported
to exert their toxicity through binding to the aryl hydrocarbon
(dioxin) receptor (AhR) which is a ligand-dependent transcription
factor. Although the AhR binding affinity of non-dioxin-like PCB
congener 153 is relatively weak compared to the AhR ligand
TCDD, PCB153 has been reported to bind the AhR at high
concentrations [34]. Therefore, we determined whether PCB153-
induced ID3 expression in ECs depended on AhR signaling by
treating with a known AhR ligand-selective antagonist, CH-
223191 [35]. Co-treatment with the CH-223191 [10 nM] did not
interfere with the PCB153-induced increase in ID3 protein
(Fig. 5B). These findings demonstrate that PCB153-induced
increase in p-Ser ID3 and total ID3 was not mediated via AhR
signaling. We and others have reported that ID3 expression is
ROS dependent in ECs. To investigate whether PCB153-induced
ROS mediated ID3 expression in hCMEC/D3, we pre-treated
ECs with the ROS scavenger N-acetylcysteine. As shown in
Fig. 5C, the treatment with N-acetylcysteine inhibited the
PCB153-induced increase of ID3 expression at 3 h in hCMEC/
D3. Because the level of ID3 protein is determined by the rates of
protein synthesis and protein degradation, we tested whether
PCB153 treatment affected the protein synthesis of ID3. As shown
in Fig. 5D, ID3 protein decreased upon treatment with the protein
synthesis inhibitor cycloheximide in the control. PCB153-treated
cells in the absence of protein synthesis showed that ID3 protein
levels remained higher than control at 3 and 6 h time points.
Thus, the observed increase in ID3 by PCB153 treatment does not
depend on protein synthesis in hCMEC/D3, but rather PCB153
made ID3 more stable from protein degradation.
Identification of phosphorylated amino acids in
microvascular endothelial ID3
Serine-5 phosphorylated ID3 has been shown to be important
for cell growth [33], although it is not known whether this is also
the case for microvascular ECs. Given that there is no
commercially available antibody specific for Ser5-phosphorylated
ID3, we performed a search for the presence of any literature-
derived kinase/phosphatase motifs in the human ID3 sequence
using the PhosphoMotif Finder program. This software program
contains experimentally characterized phosphorylation-based
substrate and binding motifs derived from the literature and has
been integrated with Human Protein Reference Database
(HPRD—http://www.hprd.org/ [36]. A search with the Phos-
phoMotif Finder program revealed that ID3 had 38 serine kinase/
phosphatase motifs and 8 tyrosine kinase/phosphatase motifs
(Table S1 and S2 in File S1) described in the literature. Based on
this information, PCB153 treatment has the potential to induce
several serine and/or tyrosine phosphorylation sites. To determine
phospho-ID3 sites induced by PCB153, cell lysates from treated
hCMEC/D3 were immunoprecipitated with ID3 and prepared
for MALDI-TOF analysis as described in Materials & Methods
section. MS spectra analysis identified with high confidence the
human ID3 sequence with the protein score of 99% from the
control sample and 94% from the PCB153 sample. Presence of
phosphorylated residues was identified by the MS/MS peak
showing neutral loss of phosphates. In control, we observed a
peptide ALS5PVRGCY11EAVCCLS18ER, m/z 2367.1738,
which corresponded to the calculated mass of the loss of phosphate
(298 Da for serine or theronine phosphorylated peptides) plus loss
of phosphate (280 Da for tyrosine phosphorylated peptide)
(Fig. 6A). We also observed a peptide ALSPVRGCY11EAVCCL-
SER, m/z 2149.8459, which corresponded to the calculated loss of
phosphate (280 Da) (Fig. 6B). In the PCB153 treatment group,
Labeling index (LI) represents the percentage of the immunostained cells per total number of cells. Corresponding graphs to each row of images
indicate a higher ID3 & 8-OHdG LI in both malignant and benign tissues compared to normal tissue (p,0.05, Mann-Whitney U-test). (E),
Immunofluorescence staining of Id3 (green) and 8-OHdG (red) in main artery tissue. Scale = 20 mm. (F) Scatter plot of IF score vs ID3 & 8-OHdG LI in
benign and normal artery tissue. IF score represents total score taken as the product of fluorescence intensity score and the cell score.
doi:10.1371/journal.pone.0104159.g004
Figure 5. PCB-induced ID3 expression is independent of AhR and ID3 protein is stablized. (A) PCB153 [5 mM] treatment increased serine
phosphorylation of ID3 protein at 3 h. ID3 protein was isolated by immunoprecipitation (IP) technique using magnetic beads and detected by
immunoblot. Serine phosphorylation of immuoprecipitated ID3 protein was determined with anti-p-Ser antibody. (B) PCB153 induced ID3 protein
was not modulated by aryl hydrocarbon receptor (AhR) at 3 h in hCMEC/D3 cell line. Western blot analysis showed that the AhR ligand-selective
antagonist, CH-223191 [10 nM], did not prevent PCB153 induced expression of ID3. (C) PCB153 induced expression of ID3 protein was inhibited by
ROS scavenger NAC in hCMEC/D3. (D) PCB153-treated cells in the absence of protein synthesis showed that ID3 protein levels remained higher than
control at 3 and 6 h time points. Cells were pretreated with the protein synthesis inhibitor cycloheximide [1 mg/ml] 2 h prior to treatment with
PCB153.
doi:10.1371/journal.pone.0104159.g005
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along with peptides where Ser-5 was detected at the level of MS,
we observed a peptide GPAAEEPLSLLDDMNHCY48SR, m/z
2298.0977, which corresponded to the calculated loss of phosphate
(280 Da) for a tyrosine phosphorylated peptide (Fig. 6C). Thus,
the peptide spectra data demonstrated that multiple amino acids
were phosphorylated on ID3. These phosphorylated amino acids
included either Ser-5 or Ser-18 in combination with Tyr-11 as
observed in the control while an additional Tyr-48 residue was
identified in the PCB153 treatment group.
PCB153 increased tyrosine phosphorylation of ID3
Although phosphorylated Ser-5 of ID3 has been reported, we
have not found any evidence from the literature of tyrosine
phosphorylated ID3. Based on our search results from Phospho-
Motif Finder, it revealed that the ID3 protein sequences at Tyr-11
and Tyr-48 corresponded to Src, JAK2, and ALK kinase substrate
motifs. We further confirmed whether PCB153-induced tyrosine
phosphorylation of ID3 protein in the hCMEC/D3 cell line.
Immunoprecipitation (IP) was performed to isolate ID3 from cell
lysate using a monoclonal anti-ID3 antibody (Cal-Bioreagent).
Magnetic bead-based separation was then used to extract the
bound ID3 protein via Protein G coupled to superparamagnetic
Dynabeads according to the manufacturer’s instructions. Proteins
from immunolysates were separated by SDS-PAGE, transferred to
PVDF membrane, and processed as described previously. Western
Blots with phosphorylated ID3 were detected by electrochemilu-
minescence (ECL). The ECL band intensity for phospho-Tyr was
imaged with a Bio-Rad Versa Doc instrument. ECs were treated
with PCB153 to determine its effect on the tyrosine phosphory-
lation state of ID3 at 6, 12, and 24 h. After 24 h of PCB153
[10 mM] treatment, we observed a significantly higher level of
tyrosine phosphorylation than vehicle control (Fig. 7). The
phospho-Tyr bands corresponded with the molecular weight
(MW) of 17 kDa for ID3. Co-treatment with a ROS scavenger was
used to determine whether it would change the level of PCB-
induced tyrosine phosphorylation, however, we did not observe a
significant effect by N-acetylcysteine (2 mM). These findings
showed that PCB153 treatment increased tyrosine phosphoryla-
tion of immunoprecipitated ID3 lysate and confirmed the MS/MS
Figure 6. Identification of phosphorylated amino acids in ID3 from microvascular ECs. MALDI-TOF/TOF spectra for peptides extracted
from hCMEC/D3 cells. Vehicle control showed that Ser-5 or Ser-18 (Panel A) and Tyr-11 (Panel B) are phosphorylated. Identification of
phosphopeptides from PCB153 treated cells indicated that along with Ser-5 that was detected at the level of MS, Tyr-48 was also phosphorylated
(Panel C). Methods: Cell lysate was immunoprecipitated with ID3 antibody from vehicle control and PCB153 treated hCMEC/D3 cells. The
immunoprecipitated lysate was separated by 1D-SDS-PAGE and the protein band corresponding to the MW of ID3 was excised from the gel,
subjected to tryptic digestion and phosphopeptide enrichment. The phosphopeptides were spotted on a MALDI plate followed by MS and database
search. The spectra of all peptides were manually evaluated for the loss of phosphate which is shown in red circles and the observed mass (dashed
circle) and sequence of the peptides are shown. X-axis represents mass and Y-axis represents intensity.
doi:10.1371/journal.pone.0104159.g006
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spectra data that showed phosphorylated amino acids Tyr-11 and
Tyr-48 in peptides from ID3.
Pyk2 mediated PCB-induced neovascularization and ID3
protein levels
Many environmental toxicants exhibit their adverse effects via
ROS signaling. Proline-rich tyrosine kinase 2 (Pyk2) represents a
novel member of the focal adhesion kinase family that is activated
by ROS in vascular cells [37]. Since the tyrosine kinase Src was
reported to regulate both Id transcript and protein levels [38], we
postulated that ID3 may be a novel target of Pyk2 signaling. We
first determined whether Pyk2 was a positive regulator of the PCB-
induced vascular phenotype by siRNA experiments as described
previously. Cells were transfected with either Pyk2 siRNA or
Silencer negative control prior to co-culture experiments. As
shown in Fig. 8, ECs immunostained with CD31 showed a
dramatic inhibition of both PCB153— and PCB77— induced
tube formation by Pyk2 siRNA. These findings demonstrated that
PCB-induced neovascular phenotype depends on Pyk2.
The activation of Pyk2 results from its autophosphorylation on
Tyr-402 (pY402), which creates a Src homology 2-binding site
(SH2). Next, we determined whether PCB153 modulated Pyk2
phosphorylation in hCMEC/D3 cells. The aim of this experiment
was to determine whether PCB153-induced ROS increased the
level of pY402 Pyk2. Cells pretreated with the ROS scavenger N-
acetylcysteine (Fig. 9A), showed significantly less PCB153-induced
Pyk2 phosphorylation then in the control panel. There have been
no reports to our knowledge of Pyk2 mediated ID3 therefore we
determined whether ID3 was a downstream effector of Pyk2
kinase. Using a loss-of-function approach with both Pyk2 kinase
inhibitor (PF431396) and siRNA, we compared the effects of
inhibiting Pyk2 on the total level of ID3 protein. To determine
whether ID3 was a downstream target of functional Pyk2 kinase,
ECs were treated with the chemical Pyk2 kinase inhibitor PF-
431396. As shown in Fig. 9B, exposure to the Pyk2 inhibitor
attenuated the level of pY402 Pyk2, however, we did not observe
any significant change in the expression of ID3 compared to
vehicle control. Pyk2 is known to phosphorylate tyrosine residues,
but because there are no commercially available anti-phosphotyr-
osine-ID3 antibodies, we determined the effect of PF-431396
treatment on the level of phospho-tyrosine at a MW of
approximately 17 kDa by stripping and re-probing ID3 immuno-
blots with anti-phosphotyrosine antibody. As expected, we
observed a significant decrease in the intensity of the phospho-
tyrosine band in cells treated with PF-431396 (Fig. 9B). Since
chemical inhibitors may exert non-specific effects, we compared
the observations from the PF-431396 treatment to siRNA
Figure 7. PCB153 increased tyrosine phosphorylation of ID3. hCMEC/D3 cells were treated with PCB153 to determine its effect on the
tyrosine phosphorylation state of ID3 at 6, 12, and 24 h. After 24 h of PCB153 [10 mM] treatment, we observed a significantly higher level of tyrosine
phosphorylation than vehicle control. The phospho-Tyr bands detected from immunoprecipitated (IP) cell lysate corresponded with the molecular
weight (MW) of 17 kDa for ID3. IP was performed to isolate ID3 from cell lysate using a monoclonal anti-ID3 antibody. Magnetic bead-based
separation was then used to extract the bound ID3 protein via Protein G coupled to superparamagnetic Dynabeads. P-Tyr was detected by
immunoblotting using the anti-phospho-Tyr antibody. Electrochemiluminescence (ECL) band intensity for phospho-Tyr was imaged with a Bio-Rad
Versa Doc instrument.
doi:10.1371/journal.pone.0104159.g007
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experiments. ECs were transfected with either Pyk2 siRNA or
Silencer negative control siRNA for 48 h prior to PCB153
treatments. As shown in Fig. 9C, Pyk2 siRNA significantly
decreased the total ID3 protein levels in the PCB153 treated
ECs when compared to cells transfected with the scrambled
siRNA control. Pyk2 siRNA treatment also inhibited the basal
expression of ID3 in the vehicle control and the level of
phosphotyrosine that corresponded to MW,17 kDa of ID3.
Taken together these findings demonstrated that Pyk2 mediates
the expression of ID3 protein. In addition, the observed PCB153-
induced increase in the level of tyrosine phosphorylation for
proteins of MW,17 kDa implied that ID3 may be a target of
Pyk2 kinase.
Pyk2 phosphorylated ID3 in vitro
Since our data from the previous experiments showed that Pyk2
siRNA significantly inhibited the levels of ID3 and tyrosine
phosphorylation for proteins of MW,17 kDa corresponding to
ID3, we postulated that Pyk2 phosphorylated ID3. Recombinant
activated Pyk2 kinase was incubated with either Flag-tagged ID3
or GST-tagged ID3 in the presence or absence of ATP; and
phosphorylation was detected by immunoblotting as described in
the Materials & Methods section. As shown in Fig. 10A, we
detected a phosphorylated tyrosine band at the corresponding
MW,13 kDA for Flag-ID3 and MW,39 kDa for GST-ID3.
Since the GST-tag from the recombinant ID3 protein may lead to
inaccurate conclusions because the tag itself has been reported to
be phosphorylated by kinase [39], we further confirmed Flag-ID3
phosphorylation status by MALDI-TOF/TOF. To identify the
ID3 amino acid residue (or residues) phosphorylated by Pyk2, we
analyzed in vitro–phosphorylated ID3 by combined MS+MS/MS
as described previously. MS spectra analysis identified with high
confidence the human ID3 sequence with the protein score of
100%. Presence of phosphorylated amino acids was identified by
the MS/MS peak showing neutral loss of phosphates. As shown in
Fig. 10B, we observed three separate phosphopeptide fragments:
MKALS5PVR, m/z 997.403; ALS5PVRGCYEAVCCLSER, m/
z 2149.8193; and ALS5PVRGCYEAVCCLSE, m/z 2206.8262
that corresponded to the calculated mass of the loss of phosphate
(298 Da for serine phosphorylated peptides). Although Pyk2
kinase has not been shown in vivo to phosphorylate serine
residues, our data indicated Ser-5 of Flag-tagged ID3 was
phosphorylated under the conditions of the kinase assay. However,
at the level of MS peptide fragments phosphorylated at Tyr-11
and Tyr-48 residues corresponding to the calculated mass of
phosphorylated fragments: GCY11EAVCCLSER, m/z 1412.5156
and GPAAEEPLSLLDDMNHCY48SR, m/z 2298.0593, respec-
tively were observed. Together these findings from the combined
MS+MS/MS data confirm that Flag-tagged ID3 is phosphorylat-
ed by active recombinant Pyk2 kinase; and support the phospho-
Tyr band that was detected at the corresponding MW,13 kDA
for Flag-ID3 by immunoblot.
Figure 8. siRNA Pyk2 inhibited the PCB-induced neovascular phenotype. PCB-induced vessel formation was characterized in a co-culture
model in which HUVECs were seeded on top of a confluent layer of fibroblasts (Fb). HUVECs were transiently transfected with either Pyk2 siRNA
[50 nM] or Silencer negative control siRNA for 48 h prior to experiments. Co-cultures immunostained for endothelial marker CD31 showed a robust
inhibition of PCB-induced neovascular network by Pyk2 siRNA when compared to cells transfected with negative control siRNA. Scrambled siRNA
(Silencer negative control siRNA, Ambion) was used in all RNAi experiments. The data shown are representative images from an experiment repeated
three separate times. HUVECs were treated with 1 ng/ml of PCB153 (2,29,4,49,5,59-hexachlorobiphenyl) or PCB77 (3,39,4,49-tetrachlorobiphenyl).
doi:10.1371/journal.pone.0104159.g008
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Stable ID3 overexpression increased cell survival of
microvascular ECs
Since our data indicated that PCB-induced neovascularization
depended on ID3 and given the biological signficiance of ID3 as a
positive regulator of cell growth, we asked whether stable
overexpression of ID3 could increase cell survival of microvascular
ECs. To address this question, adult human microvascular ECs
were transduced using a MOI of 25 with either the Precision
LentiORF for ID3 overexpression or control empty lentiviral
vector pLEX-JRED/TurboGFP according to the manufacturer’s
instructions. Cells were then seeded at clonal density and selected
with blasticidin S (5 mg/ml). Although other studies have reported
ID3 overexpression in various cell lines, this is the first report of a
stable ID3 clone in human cerebral microvascular endothelial cell
line hCMEC/D3. As shown in Fig. 11A, fluorescent microscopy
showed positive confirmation of TurboGFP expression for the
stable ID3 clone while the control cells transduced with the empty
vector express RFP and GFP. We next determined whether the
protein expression level of ID3 in our stable clone was indeed
greater than in the control. We detected a significantly higher level
of ID3 protein in the stable ID3 clone compared to the empty
vector control (Fig. 11B). Next we determined the functional
consequence of ID3 overexpression on the percentage of cells
within the hCMEC/D3 population that were actively undergoing
apoptosis. Cells were subjected to FACS analysis after FITC
Annexin V (Y-axis) and Propidium Iodide (PI: X-axis) staining
(Fig. 11C). Live cells stained negative for both FITC Annexin V
and PI and indicated that 88.74% of cell population from the ID3
clone were not undergoing measurable apoptosis compared to
only 25.74% in control. Cells which stained positive for FITC
Annexin V and negative for PI indicated that only 5.04% of the
ID3 clone population was undergoing apoptosis compared to
48.8% in the control. Dead cells that stained positive for both
FITC Annecin V and PI were 4.58% of ID3 clone population and
21.82% in the control. Thus, our data showed a significant
increase in cell survival by ID3 overexpression in hCMEC/D3
cells.
Discussion
In the present study, we determined whether PCB-induced
ROS contributed to neovascularization with the aim of elucidating
the role of environmental PCBs in endothelial dysfunction while
focused on ID3. Our study investigated the effects of PCBs on
endothelial cells because they are the cellular interface between
environmental toxicants in the circulating blood and the vessel
wall; and hence a prime target for the adverse effects of these
environmental toxicants. Enhanced neovascularization has been
implicated in either the development or progression of prolifer-
ative lesions in diabetic retinopathy, plexiform lesions in idiopathic
pulmonary arterial hypertension, and atherosclerotic lesions in
cardiovascular disease, to name a few. It is evident that humans
have been and will continue to be exposed to PCBs due to
Figure 9. PCB153 increased Pyk2 phosphorylation & Pyk2 regulated ID3 protein. (A) hCMEC/D3 cells were treated with PCB153 to
determine its effect on Pyk2 phosphorylation and whether the effect depended on ROS. PCB153-induced ROS increased the level of pY402 Pyk2 which
was inhibited by the ROS scavenger N-acetylcysteine. (B) To determine whether ID3 was a downstream target of functional Pyk2 kinase, ECs were
treated with the chemical Pyk2 kinase inhibitor PF-431396 [1 mM]. Pyk2 inhibitor inhibited the level of pY402 Pyk2, but did not change ID3 expression
compared to vehicle control. (C) Using a loss-of-function approach with siRNA Pyk2, we compared the effects of inhibiting Pyk2 on the total level of
ID3 protein. Using Lipofectamine RNAiMAX reagent (Invitrogen) ECs were transfected with either Pyk2 siRNA or Silencer negative control siRNA for
48 h prior to PCB153 treatments. Pyk2 siRNA inhibited total ID3 protein levels in both the PCB153 and vehicle control treated hCMEC/D3 cells
compared to the negative control. Pyk2 siRNA treatment also inhibited the level of phosphotyrosine that corresponded to MW,17 kDa of ID3.
doi:10.1371/journal.pone.0104159.g009
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continual inputs into the environment from landfills and inciner-
ators [40]. PCB153 is a persistent non-dioxin-like polychlorinated
biphenyl (NDL-PCB) abundantly present in the food-chain and
the environment. NDL-PCBs are known to be less toxic then
dioxin-like (DL) congeners, but may still cause deleterious public
health effects because of their tendency to bioaccumulate to high
concentrations due to their slow elimination from the human
body. In adults, the estimated elimination half-life for PCB153 is
14.4 years [41].
The effect of environmental PCBs on Id proteins has not been
investigated until now which makes the results reported in this
study novel. The major findings from this study are: (i) PCB-
induced ROS mediated a highly tube branched neovascular
phenotype that also depended on ID3 and Pyk2; (ii) PCB153
treatment increased the size of endothelial spheroids under
conditions typically used for clonal selection of stem cells; (iii)
High ID3 protein expression correlated with a greater degree of
malignancy and oxidative DNA damage marker 8-OHdG in
blood vessels; (iv) PCB153 increased ID3 protein independent of
AhR signaling which was due to protein stabilization; (v) PCB153
treatment increased both serine and tyrosine phosphorylation of
endothelial ID3; (vi) Pyk2 kinase phosphorylated ID3 in vitro; and
(vii) ID3 overexpression increased cell survival of human
microvascular endothelial cell line hCMEC/D3. Together, our
results present evidence in the support of PCB-induced ROS-
mediated Pyk2 signaling leading to the activation of ID3 which is
presumably necessary for regulating vascular EC survival and
development of microvascular lesions. These observations are
important because they provide a new paradigm by which PCBs
may contribute to the growth of microvascular lesions.
The molecular mechanisms responsible for the development of
microvascular lesions in response to exposure to PCBs are not fully
understood. Many environmental contaminants exhibit their
adverse effects via ROS mediated signaling. A considerable body
of evidence supports an important role for ROS in promoting
microvascular lesions, at least in part, through the stimulation of
growth factor signaling [42]. The majority of PCBs in plasma are
transported by albumin [43]. The albumin binding protein gp60,
Figure 10. Recombinant active Pyk2 kinase phosphorylated ID3. Pyk2 siRNA significantly inhibited tyrosine phosphorylation for proteins of
MW,17 kDa corresponding to ID3 therefore we determined whether ID3 was phosphorylated by recombinant active Pyk2 in an in vitro kinase assay.
Pyk2 kinase was incubated with either Flag-tagged ID3 or GST-tagged ID3 in the presence or absence of ATP; and phosphorylation was detected by
immunoblotting. (A) A phosphorylated tyrosine band was detected at the corresponding MW,13 kDA for FLAG-ID3 and MW,39 kDa for GST-ID3.
(B) Phosphorylation of in vitro–phosphorylated FLAG-ID3 was confirmed by combined MS+MS/MS as described previously. MS spectra analysis
identified the human ID3 sequence with the protein score of 100%. Presence of phosphorylated amino acids was identified by the MS/MS peak
showing neutral loss of phosphates which is shown in red circles and the observed mass (dashed circle). The sequence of the peptides are shown.
X-axis represents mass and Y-axis represents intensity.
doi:10.1371/journal.pone.0104159.g010
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which is localized to caveolae on the surface of ECs [44], allows for
interaction between PCBs in plasma and caveolae-associated
membrane signaling proteins that may include Pyk2. Pyk2
represents a novel member of the focal adhesion kinase family
that is activated by ROS in vascular cells [37]. In the present
study, we have not identified the detailed mechanism by which the
PCB-induced ROS upregulated ID3 levels. However, our data
indicate that there are post-translational effects that increase
protein stabilization which have functional consequences for
neovascularization. Our findings did show that PCB-induced
Pyk2 activation depends on ROS in hCMEC/D3 cells. Pyk2
activation results from its autophosphorylation on Tyr-402, which
creates a SH2 binding domain. Since the SH2 domain recruits
other proteins to Pyk2, these protein-protein interactions may be
important for signaling to ID3. Although it still needs to be
confirmed in vivo, our data show that Pyk2 kinase can
phosphorylate ID3. Thus, Pyk2 mediated signaling to ID3 may
be one possible pathway for PCB-induced neovascularization. It is
not clear whether PCB153-induced phospho-ID3 leads to protein-
protein interactions or nuclear translocation that may prevent its
degradation; however, our findings demonstrated that ID3 is a
target of post-translational modifications by PCB153 in microvas-
cular ECs. Results from the cardiovascular tissue microarray
provide further support that ID3 plays a role in vascular disease as
ID3 expression correlated with both grade of malignancy and 8-
OHdG in blood vessels. If a marker of oxidative DNA damage 8-
OHdG is used as a surrogate for oxidative stress, then it is
plausible that oxidative stress commonly found in malignant tissues
may mediate the high ID3 levels via ROS signaling pathways. It is
known that cells exposed chronically to toxic chemicals adapt to
survive and develop resistance to cell death. ID3 is not only
activated by PCB-induced ROS, but we observed that PCB153
provided a growth advantage. We showed that PCB153 treatment
increased the size of endothelial spheroids that is most likely due to
increased cell survival and is corroborated by a report of increased
cell survival by chronic in vitro PCB153 (50–100 mM) 12 wk
exposure [45]. It is becoming increasingly recognized that the
pathogenesis of microvascular complications includes disordered
proliferation of ECs. Our data showed that ID3 overexpression
increased cell survival; hence PCB-induced ID3 may support
survival of damaged ECs that contribute to the formation of a
microvascular lesion. The increase in cell survival may explain the
formation of reported hyper-proliferative, apoptosis-resistant, and
monoclonal ECs found in microvascular lesions.
Epidemiological studies of human PCB exposure have shown
that PCB153 had the highest serum levels among PCB congeners
[46]. The endothelial phenotype changes in our study were
observed at a 1 ng/ml dose of PCB153 which is within the
reported range of PCB153 [0.60–1.63 ng/ml] found in human
serum [47]. Thus, our findings are of significant public health
importance because they showed that endothelial phenotype
changes occurred in vitro by reported doses of PCBs found in
human serum. The mechanistic implications of our findings on
PCB153-induced ID3 may be with its connection to metabolic
syndrome. Metabolic syndrome is the name for a group of risk
factors often characterized by oxidative stress that raises one’s risk
for cardiovascular disease and other health problems such as
diabetes in which microvascular lesions are found. PCBs have
been associated with metabolic syndrome in epidemiological
studies [48]. In the mouse model, PCB153 has been shown to
produce significant metabolic changes when administered with a
high fat diet that were consistent with worsened obesity and
Figure 11. ID3 overexpression increased cell survival of ECs. The functional significance of ID3 on survival of hCMEC/D3 cells was determined
by generating a stable ID3 overexpressing cell line. (A) and (B) Confirmation of ID3 overexpression in a stable clone of hCMEC/D3 cells was shown by
both immunoflouorscence microscopy and immunoblot of ID3 levels. (C) Cells were subjected to FACS analysis after FITC Annexin V (Y-axis) and
Propidium Iodide (PI: X-axis) staining. ID3 clone indicated a greater percentage of live cells stained negative for both FITC Annexin V and PI. ID3 clone
showed 88.74% of cell population was not apoptotic compared to a far lower percentage of 25.74% live cells in the control.
doi:10.1371/journal.pone.0104159.g011
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nonalcoholic fatty liver disease pathology [49]. ID3 may contrib-
ute to metabolic syndrome via its effects on obesity because animal
models have already shown that ID3-induced visceral fat
expansion in mice fed a high-fat diet [50]. It was not known
why ID3 deficient mice showed higher energy expenditure and
higher metabolic rate at rest, although previous studies have
indicated that ID3 is regulated by glucose in pancreatic islet b-cells
[51]; and in macrophage cells under chronic hyperglycemic
conditions the closely related family member Id2 was reported to
be glycosylated and protein levels stabilized which in turn had
functional effects on metabolic genes [52]. A causal link of diabetes
and microvascular complications is chronic hyperglycemia. More
importantly, however, is that mitochondrial ROS produced by
ECs in hyperglycemic conditions may share a pathway similar to
environmental toxicant induced oxidative stress which converges
on ID3. Since the findings from our study showed that PCB153-
induced ROS modulated ID3 protein levels and post-translational
modifications, our future investigations are focused on how
exposure to environmental PCBs may form a risk factor for the
development of metabolic syndrome and altering metabolism
through ID3 regulation.
In summary, the major novel findings which emerged from this
study are that PCB-induced ROS-mediated Pyk2 signaling leading
to the activation of ID3 is presumably necessary for regulating
vascular endothelial cell survival and development of microvascu-
lar lesions. A better understanding of how microvascular lesions
depend on ID3 molecular targets may open up new avenues for
prevention and treatment of vascular diseases in populations
sensitive to environmental toxicant exposures.
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